irasia.com - Investor Relations Asia Pacific
HOME

Mesoblast Limited

Announcements / Press Releases


Please download the latest "Acrobat Reader" to view the PDF.

  • 2009-December-21
  • Mesoblast - National Electronic Media Coverage (in PDF)
  • 2009-December-18
  • Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes (in PDF)
  • 2009-November-30
  • A Year of Solid Progress Address by Mesoblast Chairman, Mr Brian Jamieson; 2009 Annual General Meeting (in PDF)
  • 2009-November-18
  • Sustained Six-Month Improvement in Heart Muscle Function by "off-the-shelf" Adult Stem Cells (in PDF)
  • 2009-November-6
  • Successful Bone Marrow Regeneration in Cancer Patients Using Cord Blood Expanded by Proprietary Stem Cells (in PDF)
  • 2009-October-28
  • Notice of 2009 Annual General Meeting (in PDF)
  • 2009-October-26
  • The CEO Transcript - Investor Briefing with Silviu Itescu, Executive Director, Mesoblast Limited (in PDF)
  • 2009-October-16
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2009-October-12
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2009-October-6
  • Form 605 - Notice of Ceasing to be a Substantial Holder (in PDF)
  • 2009-September-30
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2009-September-24
  • UBS Life Sciences Investor Conference in United States Features Associate Company Angioblast (in PDF)
  • 2009-September-22
  • Enrolment Complete for Second Group of Heart Failure Patients Treated with "Off-The-Shelf" Adult Stem Cells (in PDF)
  • 2009-September-15
  • Mesoblast Disc Repair Results Highlighted at Key Orthopaedic Conference (in PDF)
  • 2009-September-10
  • Mesoblast's Proprietary Stem Cells Successfully Repair/Regenerate Damaged Intervertebral Disc Cartilage (in PDF)
  • 2009-September-1
  • The CEO Transcript - Investor Briefing with Silviu Itescu, Executive Director, Mesoblast Limited (in PDF)
  • 2009-August-26
  • Appendix 4E - Preliminary Final Report Year Ending on 30 June 2009 (in PDF)
  • 2009-August-26
  • Financial Year End Results, Mesoblast Delivers on Broadening Product Portfolio (in PDF)
  • 2009-August-25
  • United States Associate Company Angioblast Closes $10M Equity-Based Financing (in PDF)
  • 2009-August-19
  • Mesoblast's Associate Company, Angioblast Systems, Secures New Capital (in PDF)
  • 2009-August-17
  • Mesoblast Gains US FDA Clearance for Phase 2 Trial in Minimally Invasive Lumbar Spinal Fusion Surgery (in PDF)
  • 2009-August-5
  • Proprietary Technology in World-First Allogeneic Stem Cell Trial for Treatment of End-Stage Heart Failure in Patients Supported by Mechanical Heart Assist Devices (in PDF)
  • 2009-July-30
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2009-July-30
  • Letter from the Chairman (in PDF)
  • 2009-July-23
  • Mesoblast to Apply for Regulatory Approval of its Bone Fracture Repair Products (in PDF)
  • 2009-June-30
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2009-June-26
  • Mesoblast Featured on ABC-TV's Catalyst Program (in PDF)
  • 2009-June-24
  • First Patients in Bone Marrow Transplant Trial Show Earlier Engraftment (in PDF)
  • 2009-May-14
  • Heart Muscle Function Improved Significantly after Single, Lowest-Dose Injection of "off-the-shelf" Stem Cells in Patients with Heart Failure (in PDF)
  • 2009-May-5
  • Letter from the Chairman (in PDF)
  • 2009-May-1
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2009-April-28
  • Mesoblast Commences Clinical Program for Fusion of Cervical Spine (in PDF)
  • 2009-April-8
  • Form 603 - Notice of Initial Substantial Holder (in PDF)
  • 2009-April-7
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2009-April-2
  • Form 604 - Notice of Change of Interests of Substantial Holder (in PDF)
  • 2009-April-2
  • Section 708A Notice - Issue of Shares Under Private Placement to Wholesale Investors (in PDF)
  • 2009-April-2
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2009-March-30
  • Mesoblast Raises Capital for New Clinical Programs (in PDF)
  • 2009-March-26
  • Trading Halt (in PDF)
  • 2009-March-23
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2009-February-27
  • Mesoblast Results Highlighted at Key Orthopaedic Conferences (in PDF)
  • 2009-February-26
  • Half-Year Results, Emerging Portfolio of Clinical Products Underpin Commercial Strategic Objectives (in PDF)
  • 2009-February-26
  • Appendix 4D - Half Year Report for the Six months to 31 December 2008 (in PDF)
  • 2009-February-25
  • First Group of Heart Failure Patients Treated with "Off-The-Shelf" Adult Stem Cells Successfully Pass Key Safety Milestone (in PDF)
  • 2009-February-16
  • ParkwayHealth and Mesoblast to Provide Cutting Edge Treatment Using Proprietary Adult Stem Cells (in PDF)
  • 2009-January-30
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2009-January-20
  • Mesoblast Stem Cells Approved for World First Osteoarthritis Clinical Trial (in PDF)
  • 2009-January-6
  • Mesoblast Named 2009 North American Emerging Company by Frost & Sullivan (in PDF)
  • 2017
  • 2017 Announcements / Press Releases
  • 2016
  • 2016 Announcements / Press Releases
  • 2015
  • 2015 Announcements / Press Releases
  • 2014
  • 2014 Announcements / Press Releases
  • 2013
  • 2013 Announcements / Press Releases
  • 2012
  • 2012 Announcements / Press Releases
  • 2011
  • 2011 Announcements / Press Releases
  • 2010
  • 2010 Announcements / Press Releases
  • 2008
  • 2008 Announcements / Press Releases
  • 2007
  • 2007 Announcements / Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.